Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (8133)
All Articles published online
|
Publishing Process of This Article
|
May 7, 2014 (publication date) through Nov 22, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Fleischman MW, Budoff M, Zeb I, Li D, Foster T. NAFLD prevalence differs among hispanic subgroups: The multi-ethnic study of atherosclerosis. World J Gastroenterol 2014; 20(17): 4987-4993 [PMID: 24803810 DOI: 10.3748/wjg.v20.i17.4987] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v20/i17/4987.htm |
| Number | Citing Articles |
| 1 |
Roxana Gutiérrez-Vidal, Blanca Delgado-Coello, Kevin Manuel Méndez-Acevedo, Sandra Calixto-Tlacomulco, Salvador Damián-Zamacona, Jaime Mas-Oliva. Therapeutic Intranasal Vaccine HB-ATV-8 Prevents Atherogenesis and Non-alcoholic Fatty Liver Disease in a Pig Model of Atherosclerosis. Archives of Medical Research 2018; 49(7): 456 doi: 10.1016/j.arcmed.2019.01.007
|
| 2 |
Daria L Varganova, Chavdar S Pavlov, Giovanni Casazza, Dimitrinka Nikolova, Christian Gluud. Essential phospholipids for people with non-alcoholic fatty liver disease. Cochrane Database of Systematic Reviews 2019; doi: 10.1002/14651858.CD013301
|
| 3 |
Thomas G. Cotter, Mary Rinella. Nonalcoholic Fatty Liver Disease 2020: The State of the Disease. Gastroenterology 2020; 158(7): 1851 doi: 10.1053/j.gastro.2020.01.052
|
| 4 |
Uchenna Agbim, Rotonya M. Carr, Octavia Pickett-Blakely, Sam Dagogo-Jack. Ethnic Disparities in Adiposity: Focus on Non-alcoholic Fatty Liver Disease, Visceral, and Generalized Obesity. Current Obesity Reports 2019; 8(3): 243 doi: 10.1007/s13679-019-00349-x
|
| 5 |
Chaojie Yang, Brian Hallmark, Jin Choul Chai, Timothy D. O’Connor, Lindsay M. Reynolds, Alexis C. Wood, Michael Seeds, Yii-Der Ida Chen, Lyn M. Steffen, Michael Y. Tsai, Robert C. Kaplan, Martha L. Daviglus, Lawrence J. Mandarino, Amanda M. Fretts, Rozenn N. Lemaitre, Dawn K. Coletta, Sarah A. Blomquist, Laurel M. Johnstone, Chandra Tontsch, Qibin Qi, Ingo Ruczinski, Stephen S. Rich, Rasika A. Mathias, Floyd H. Chilton, Ani Manichaikul. Impact of Amerind ancestry and FADS genetic variation on omega-3 deficiency and cardiometabolic traits in Hispanic populations. Communications Biology 2021; 4(1) doi: 10.1038/s42003-021-02431-4
|
| 6 |
Zobair M. Younossi, Linda Henry, Haley Bush, Alita Mishra. Clinical and Economic Burden of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis. Clinics in Liver Disease 2018; 22(1): 1 doi: 10.1016/j.cld.2017.08.001
|
| 7 |
Lindsay Spitz, Stefan Saadiq, Navkiran K. Shokar, Marc J. Zuckerman, Nancy A. Casner, Roy Valenzuela, Jennifer J. Salinas. Characterization of an At-Risk Population for Nonalcoholic Fatty Liver Disease (NAFLD) in a Primary Care Setting Along the U.S.–Mexico Border. Journal of Transcultural Nursing 2024; doi: 10.1177/10436596241271265
|
| 8 |
|
| 9 |
Melissa Lopez-Pentecost, Martha Tamez, Josiemer Mattei, Elizabeth T. Jacobs, Cynthia A. Thomson, David O. Garcia. Adherence to a Traditional Mexican Diet Is Associated with Lower Hepatic Steatosis in US-Born Hispanics of Mexican Descent with Overweight or Obesity. Nutrients 2023; 15(23): 4997 doi: 10.3390/nu15234997
|
| 10 |
Siti Aishah Sulaiman, Vicneswarry Dorairaj, Muhammad Nafiz Haidi Adrus. Genetic Polymorphisms and Diversity in Nonalcoholic Fatty Liver Disease (NAFLD): A Mini Review. Biomedicines 2022; 11(1): 106 doi: 10.3390/biomedicines11010106
|
| 11 |
Yutao Zhan, Ping Xie, Dongnian Li, Li Li, Jing Chen, Wei An, Lingqiang Zhang, Chuan Zhang. Deficiency of CKIP-1 aggravates high-fat diet-induced fatty liver in mice. Experimental Cell Research 2017; 355(1): 40 doi: 10.1016/j.yexcr.2017.03.033
|
| 12 |
Lilah M. Besser, Sarah N. Forrester, Milla Arabadjian, Michael P. Bancks, Margaret Culkin, Kathleen M. Hayden, Elaine T. Le, Isabelle Pierre-Louis, Jana A. Hirsch, Andrea Da Porto. Structural and social determinants of health: The multi-ethnic study of atherosclerosis. PLOS ONE 2024; 19(11): e0313625 doi: 10.1371/journal.pone.0313625
|
| 13 |
Hai Duc Nguyen, Min-Sun Kim. Effects of chemical mixtures on liver function biomarkers in the Korean adult population: thresholds and molecular mechanisms for non-alcoholic fatty liver disease involved. Environmental Science and Pollution Research 2022; 29(52): 78555 doi: 10.1007/s11356-022-21090-4
|
| 14 |
Rosa Lombardi, Simona Onali, Douglas Thorburn, Brian R Davidson, Kurinchi Selvan Gurusamy, Emmanuel Tsochatzis. Pharmacological interventions for non-alcohol related fatty liver disease (NAFLD). Cochrane Database of Systematic Reviews 2017; 2017(4) doi: 10.1002/14651858.CD011640.pub2
|
| 15 |
Melissa Lopez-Pentecost, Brian Hallmark, Cynthia A. Thomson, Floyd Chilton, David O. Garcia. Association between Dietary Fatty Acid Intake and Liver Steatosis and Fibrosis in a Sample of Mexican-Origin Hispanic Adults with Overweight or Obesity. International Journal of Environmental Research and Public Health 2023; 20(4): 3103 doi: 10.3390/ijerph20043103
|
| 16 |
Rosemay A. Remigio-Baker, Matthew A. Allison, Nketi I. Forbang, Rohit Loomba, Cheryl A.M. Anderson, Matthew Budoff, Jeffrey B. Schwimmer, Roger S. Blumenthal, Pamela Ouyang, Michael H. Criqui. Race/ethnic and sex disparities in the non-alcoholic fatty liver disease-abdominal aortic calcification association: The Multi-Ethnic Study of Atherosclerosis. Atherosclerosis 2017; 258: 89 doi: 10.1016/j.atherosclerosis.2016.11.021
|
| 17 |
J.A. Weintraub, G. Lopez Mitnik, B.A. Dye. Oral Diseases Associated with Nonalcoholic Fatty Liver Disease in the United States. Journal of Dental Research 2019; 98(11): 1219 doi: 10.1177/0022034519866442
|
| 18 |
Utibe-Abasi Udoh, Juan D Sanabria, Pradeep K Rajan, Moumita Banerjee, Mathew Schade, Jacqueline A Sanabria, Gary Smith, Gideon Udoh, Komal Sodhi, Sandrine Pierre, Joseph I Shapiro, Juan R Sanabria. Liver Cancer. 2021; : 55 doi: 10.36255/exonpublications.livercancer.2021.ch3
|
| 19 |
Luis Antonio Díaz, Marcela Villota-Rivas, Francisco Barrera, Jeffrey V. Lazarus, Marco Arrese. The burden of liver disease in Latin America. Annals of Hepatology 2024; 29(3): 101175 doi: 10.1016/j.aohep.2023.101175
|
| 20 |
Lorena Fecury Tavares, Mariana Rosa Bernardo, Kalil Orleans Silveira Pinho, Ana Paula Santos Oliveira Brito, Rodrigo Bona Maneschy, Hamilton Cezar Rocha de Garcia. Doença Hepática Gordurosa Não Alcoólica - Diagnóstico e tratamento. Pará Research Medical Journal 2022; 3(2): 1 doi: 10.4322/prmj.2019.011
|
| 21 |
Rotonya M. Carr, Amanke Oranu, Vandana Khungar. Nonalcoholic Fatty Liver Disease. Gastroenterology Clinics of North America 2016; 45(4): 639 doi: 10.1016/j.gtc.2016.07.003
|
| 22 |
Huei-Wen Lim, David E. Bernstein. Risk Factors for the Development of Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis, Including Genetics. Clinics in Liver Disease 2018; 22(1): 39 doi: 10.1016/j.cld.2017.08.008
|
| 23 |
Julia Y. Payne, Naim Alkhouri, Phuc Le, Michael B. Rothberg, Prido Polanco, Celine Sakkal, Srinivasan Dasarathy. Prevalence of at-risk NASH and its association with metabolic syndrome in US adults with NAFLD, 2017–2018. Hepatology Communications 2023; 7(1): e0019 doi: 10.1097/HC9.0000000000000019
|
| 24 |
Julia Kozlitina, Silvia Sookoian. Global Epidemiological Impact of PNPLA3 I148M on Liver Disease. Liver International 2024; doi: 10.1111/liv.16123
|
| 25 |
Paulina Vidal‐Cevallos, Aldo Torre, Nahum Mendez‐Sanchez, Misael Uribe, Norberto C. Chavez‐Tapia. Epidemiological and Genetic Aspects of NAFLD and NASH in Mexico. Clinical Liver Disease 2022; 19(2): 68 doi: 10.1002/cld.1167
|
| 26 |
Emir Muzurović, Carol Chiung-Hui Peng, Matthew J. Belanger, Despina Sanoudou, Dimitri P. Mikhailidis, Christos S. Mantzoros. Nonalcoholic Fatty Liver Disease and Cardiovascular Disease: a Review of Shared Cardiometabolic Risk Factors. Hypertension 2022; 79(7): 1319 doi: 10.1161/HYPERTENSIONAHA.122.17982
|
| 27 |
Zobair Younossi, Quentin M. Anstee, Milena Marietti, Timothy Hardy, Linda Henry, Mohammed Eslam, Jacob George, Elisabetta Bugianesi. Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention. Nature Reviews Gastroenterology & Hepatology 2018; 15(1): 11 doi: 10.1038/nrgastro.2017.109
|
| 28 |
Kurinchi Selvan Gurusamy, Emmanuel Tsochatzis, Angela M Madden. Nutritional supplementation for non-alcohol-related fatty liver disease: a network meta-analysis. Cochrane Database of Systematic Reviews 2018; doi: 10.1002/14651858.CD013157
|
| 29 |
Magda Shaheen, Deyu Pan, Katrina M. Schrode, Dulcie Kermah, Vishwajeet Puri, Ali Zarrinpar, David Elisha, Sonia M. Najjar, Theodore C. Friedman. Reassessment of the Hispanic Disparity: Hepatic Steatosis Is More Prevalent in Mexican Americans Than Other Hispanics. Hepatology Communications 2021; 5(12): 2068 doi: 10.1002/hep4.1775
|
| 30 |
Edgar A. Villavicencio, Rebecca M. Crocker, David O. Garcia. A Qualitative Analysis of Mexican-Origin Men’s Knowledge and Cultural Attitudes Toward Non-Alcoholic Fatty Liver Disease and Interest in Risk Reduction. American Journal of Men's Health 2021; 15(6) doi: 10.1177/15579883211063335
|
| 31 |
Maria Luz Fernandez, Sarah A. Blomquist, Brian Hallmark, Floyd H. Chilton. Omega-3 Supplementation and Heart Disease: A Population-Based Diet by Gene Analysis of Clinical Trial Outcomes. Nutrients 2021; 13(7): 2154 doi: 10.3390/nu13072154
|
| 32 |
Lankai Cathy Xu, Maricela Rangel-Garcia, Rogelio Pinon-Gutierrez, Jeffrey R Fine, Valentina Medici, Alessio Molfino. Liver fibrosis prediction models in a population of Latina and White women. Journal of Investigative Medicine 2024; 72(7): 697 doi: 10.1177/10815589241262004
|
| 33 |
Johanna K. DiStefano, Gabriel Q. Shaibi. The relationship between excessive dietary fructose consumption and paediatric fatty liver disease. Pediatric Obesity 2021; 16(6) doi: 10.1111/ijpo.12759
|
| 34 |
Caesar Ferrari, Bilal Ashraf, Zainab Saeed, Micheal Tadros. Understanding Why Metabolic-Dysfunction-Associated Steatohepatitis Lags Behind Hepatitis C in Therapeutic Development and Treatment Advances. Gastroenterology Insights 2024; 15(4): 944 doi: 10.3390/gastroent15040066
|
| 35 |
Marlen Ivon Castellanos-Fernandez, Shreya C. Pal, Marco Arrese, Juan Pablo Arab, Jacob George, Nahum Méndez-Sánchez. Nonalcoholic Fatty Liver Disease in Latin America and Australia. Clinics in Liver Disease 2023; 27(2): 301 doi: 10.1016/j.cld.2023.01.015
|
| 36 |
Mario Jesus Trejo, Kristin E. Morrill, Yann C. Klimentidis, David O. Garcia. Examining genetic associations with hepatic steatosis in Mexican-origin adults. Annals of Hepatology 2023; 28(5): 101120 doi: 10.1016/j.aohep.2023.101120
|
| 37 |
Marica Meroni, Miriam Longo, Paola Dongiovanni. Genetic and metabolic factors: the perfect combination to treat metabolic associated fatty liver disease. Exploration of Medicine 2020; 1(4): 218 doi: 10.37349/emed.2020.00015
|
| 38 |
Pegah Golabi, Vasily Isakov, Zobair M. Younossi. Nonalcoholic Fatty Liver Disease: Disease Burden and Disease Awareness. Clinics in Liver Disease 2023; 27(2): 173 doi: 10.1016/j.cld.2023.01.001
|
| 39 |
Yueying Qi, Lirong Fan, Decong Ran, Jieda Xu, Yuansong Wang, Jin Wu, Zhongyong Zhang, Muhammad Wasim Khan. Main Risk Factors of Type 2 Diabetes Mellitus with Nonalcoholic Fatty Liver Disease and Hepatocellular Carcinoma. Journal of Oncology 2021; 2021: 1 doi: 10.1155/2021/7764817
|
| 40 |
Elena Buzzetti, Audrey Linden, Lawrence MJ Best, Angela M Madden, Danielle Roberts, Thomas J G Chase, Suzanne C Freeman, Nicola J Cooper, Alex J Sutton, Dominic Fritche, Elisabeth Jane Milne, Kathy Wright, Chavdar S Pavlov, Brian R Davidson, Emmanuel Tsochatzis, Kurinchi Selvan Gurusamy. Lifestyle modifications for nonalcohol-related fatty liver disease: a network meta-analysis. Cochrane Database of Systematic Reviews 2021; 2021(6) doi: 10.1002/14651858.CD013156.pub2
|
| 41 |
Jeff S. Volek, Jonathan Clinthorne, William S. Yancy Jr. Applying a nutrition security lens to the Dietary Guidelines for Americans to address metabolic health. Frontiers in Nutrition 2023; 10 doi: 10.3389/fnut.2023.1141859
|
| 42 |
Julia Kozlitina. Genetic Risk Factors and Disease Modifiers of Nonalcoholic Steatohepatitis. Gastroenterology Clinics of North America 2020; 49(1): 25 doi: 10.1016/j.gtc.2019.09.001
|
| 43 |
Yvonne Huber, Jörn M. Schattenberg. Nicht-alkoholische Fettlebererkrankung. 2022; : 1 doi: 10.1007/978-3-662-62484-5_1
|
| 44 |
A. Rivera-Andrade, M.F. Kroker-Lobos, M. Lazo, N.D. Freedman, J.W. Smith, O. Torres, K.A. McGlynn, J.D. Groopman, E. Guallar, M. Ramirez-Zea. High prevalence of non-alcoholic fatty liver disease and metabolic risk factors in Guatemala: A population-based study. Nutrition, Metabolism and Cardiovascular Diseases 2019; 29(2): 191 doi: 10.1016/j.numecd.2018.10.008
|
| 45 |
Harshad Devarbhavi, Sumeet K. Asrani, Juan Pablo Arab, Yvonne Ayerki Nartey, Elisa Pose, Patrick S. Kamath. Global burden of liver disease: 2023 update. Journal of Hepatology 2023; 79(2): 516 doi: 10.1016/j.jhep.2023.03.017
|
| 46 |
Tongtong Wang, Yuzhi Xi, Annaswamy Raji, Michael Crutchlow, Gail Fernandes, Samuel S Engel, Xiao Zhang. Overall and subgroup prevalence of non-alcoholic fatty liver disease and prevalence of advanced fibrosis in the United States: An updated national estimate in National Health and Nutrition Examination Survey (NHANES) 2011-2018. Annals of Hepatology 2024; 29(1): 101154 doi: 10.1016/j.aohep.2023.101154
|
| 47 |
Pegah Golabi, Mehmet Sayiner, Yousef Fazel, Aaron Koenig, Linda Henry, Zobair M Younossi. Current complications and challenges in nonalcoholic steatohepatitis screening and diagnosis. Expert Review of Gastroenterology & Hepatology 2016; 10(1): 63 doi: 10.1586/17474124.2016.1099433
|
| 48 |
David O. Garcia, Kristin E. Morrill, Melissa Lopez‐Pentecost, Edgar A. Villavicencio, Rosa M. Vogel, Melanie L. Bell, Yann C. Klimentidis, David G. Marrero, Cynthia A. Thomson. Nonalcoholic Fatty Liver Disease and Associated Risk Factors in a Community‐Based Sample of Mexican‐Origin Adults. Hepatology Communications 2022; 6(6): 1322 doi: 10.1002/hep4.1896
|
| 49 |
Ethan M. Weinberg, Huy N. Trinh, Roberto J. Firpi, Kalyan Ram Bhamidimarri, Samuel Klein, Jonathan Durlam, Stephanie Watkins, K. Rajender Reddy, Michael Weiss, Richard C. Zink, Anna S. Lok. Lean Americans With Nonalcoholic Fatty Liver Disease Have Lower Rates of Cirrhosis and Comorbid Diseases. Clinical Gastroenterology and Hepatology 2021; 19(5): 996 doi: 10.1016/j.cgh.2020.06.066
|
| 50 |
Pedro Ochoa-Allemant, Jorge A. Marrero, Marina Serper. Racial and ethnic differences and the role of unfavorable social determinants of health across steatotic liver disease subtypes in the United States. Hepatology Communications 2023; 7(12) doi: 10.1097/HC9.0000000000000324
|
| 51 |
George Cholankeril, Ronak Patel, Sandeep Khurana, Sanjaya K Satapathy. Hepatocellular carcinoma in non-alcoholic steatohepatitis: Current knowledge and implications for management. World Journal of Hepatology 2017; 9(11): 533-543 doi: 10.4254/wjh.v9.i11.533
|
| 52 |
Hadi Emamat, Hossein Farhadnejad, Hossein Poustchi, Azita Hekmatdoost. Galactose intake is related to nonalcoholic fatty liver disease. Nutrition & Food Science 2019; 49(3): 359 doi: 10.1108/NFS-06-2018-0174
|
| 53 |
M. H. Le, Y. H. Yeo, R. Cheung, V. W.-S. Wong, M. H. Nguyen. Ethnic influence on nonalcoholic fatty liver disease prevalence and lack of disease awareness in the United States, 2011–2016. Journal of Internal Medicine 2020; 287(6): 711 doi: 10.1111/joim.13035
|
| 54 |
Kristin E. Morrill, Victoria L. Bland, Yann C. Klimentidis, Melanie D. Hingle, Cynthia A. Thomson, David O. Garcia. Assessing Interactions between PNPLA3 and Dietary Intake on Liver Steatosis in Mexican-Origin Adults. International Journal of Environmental Research and Public Health 2021; 18(13): 7055 doi: 10.3390/ijerph18137055
|
| 55 |
Huapeng Lin, Xinrong Zhang, Guanlin Li, Grace Lai-Hung Wong, Vincent Wai-Sun Wong. Epidemiology and Clinical Outcomes of Metabolic (Dysfunction)-associated Fatty Liver Disease. Journal of Clinical and Translational Hepatology 2021; 0(000): 000 doi: 10.14218/JCTH.2021.00201
|
| 56 |
Lorena S. Pacheco, Ryan D. Bradley, Cheryl A. M. Anderson, Matthew A. Allison. Changes in Biomarkers of Non-Alcoholic Fatty Liver Disease (NAFLD) upon Access to Avocados in Hispanic/Latino Adults: Secondary Data Analysis of a Cluster Randomized Controlled Trial. Nutrients 2022; 14(13): 2744 doi: 10.3390/nu14132744
|
| 57 |
Mariana Lazo, Usama Bilal, Rafael Perez-Escamilla. Epidemiology of NAFLD and Type 2 Diabetes: Health Disparities Among Persons of Hispanic Origin. Current Diabetes Reports 2015; 15(12) doi: 10.1007/s11892-015-0674-6
|
| 58 |
Kurinchi Selvan Gurusamy, Douglas Thorburn, Brian R Davidson, Emmanuel Tsochatzis, Kurinchi Selvan Gurusamy. Cochrane Database of Systematic Reviews. 2015; doi: 10.1002/14651858.CD011640
|
| 59 |
Zahra Sadeghianpour, Bahman Cheraghian, Hamid Reza Farshchi, Mohsen Asadi-Lari. Non-alcoholic fatty liver disease and socioeconomic determinants in an Iranian cohort study. BMC Gastroenterology 2023; 23(1) doi: 10.1186/s12876-023-02964-4
|
| 60 |
Yutao Zhan, Fei Zhao, Ping Xie, Leping Zhong, Dongnian Li, Qujing Gai, Li Li, Hongshan Wei, Lingqiang Zhang, Wei An. Mechanism of the effect of glycosyltransferase GLT8D2 on fatty liver. Lipids in Health and Disease 2015; 14(1) doi: 10.1186/s12944-015-0040-3
|
| 61 |
Hadi Emamat, Hamid Ghalandari, Ali Saneei Totmaj, Hadith Tangestani, Azita Hekmatdoost. Calcium to magnesium intake ratio and non-alcoholic fatty liver disease development: a case-control study. BMC Endocrine Disorders 2021; 21(1) doi: 10.1186/s12902-021-00721-w
|
| 62 |
Monica M. Betancourt-Garcia, Armando Arguelles, Jorge Montes, Ambrosio Hernandez, Manish Singh, R. Armour Forse. Pediatric Nonalcoholic Fatty Liver Disease: the Rise of a Lethal Disease Among Mexican American Hispanic Children. Obesity Surgery 2017; 27(1): 236 doi: 10.1007/s11695-016-2440-5
|
| 63 |
Kiarash Riazi, Mark G. Swain, Stephen E. Congly, Gilaad G. Kaplan, Abdel-Aziz Shaheen. Race and Ethnicity in Non-Alcoholic Fatty Liver Disease (NAFLD): A Narrative Review. Nutrients 2022; 14(21): 4556 doi: 10.3390/nu14214556
|
| 64 |
Anita Krishnarao, Carmi S. Punzalan. National and Global Ethnicity Differences in Non-alcoholic Fatty Liver Disease. Current Hepatology Reports 2020; 19(4): 429 doi: 10.1007/s11901-020-00552-8
|
| 65 |
Seyed Ali Hosseinian, Jamshid Mehrzad, Seyed Reza Mirhafez, Jafar Saeidi, Rahele Zhiani, Amirhossein Sahebkar. Evaluation of the effect of phytosomal curcuminoids on oxidative stress and inflammatory markers in NAFLD: A randomized double-blind placebo-controlled trial. Journal of Functional Foods 2022; 96: 105202 doi: 10.1016/j.jff.2022.105202
|
| 66 |
Eduardo Velasco-Mondragon, Angela Jimenez, Anna G. Palladino-Davis, Dawn Davis, Jose A. Escamilla-Cejudo. Hispanic health in the USA: a scoping review of the literature. Public Health Reviews 2016; 37(1) doi: 10.1186/s40985-016-0043-2
|
| 67 |
Sammy Saab, Vignan Manne, Jose Nieto, Jeffrey B. Schwimmer, Naga P. Chalasani. Nonalcoholic Fatty Liver Disease in Latinos. Clinical Gastroenterology and Hepatology 2016; 14(1): 5 doi: 10.1016/j.cgh.2015.05.001
|
| 68 |
Madison N. LeCroy, Rachel Suss, Rienna G. Russo, Sonia Sifuentes, Jeannette M. Beasley, R. Gabriela Barajas-Gonzalez, Perla Chebli, Victoria Foster, Simona C. Kwon, Chau Trinh-Shevrin, Stella S. Yi. Looking Across and Within: Immigration as a Unifying Structural Factor Impacting Cardiometabolic Health and Diet. Ethnicity & Disease 2023; 33(2-3): 130 doi: 10.18865/ed.33.2-3.130
|
| 69 |
Johanna K. DiStefano, Ignazio S. Piras, Xiumei Wu, Ritin Sharma, Krystine Garcia-Mansfield, Maya Willey, Brooke Lovell, Patrick Pirrotte, Micah L. Olson, Gabriel Q. Shaibi. Changes in proteomic cargo of circulating extracellular vesicles in response to lifestyle intervention in adolescents with hepatic steatosis. Clinical Nutrition ESPEN 2024; 60: 333 doi: 10.1016/j.clnesp.2024.02.024
|
| 70 |
Ma Ai Thanda Han, Qi Yu, Zaid Tafesh, Nikolaos Pyrsopoulos. Diversity in NAFLD: A Review of Manifestations of Nonalcoholic Fatty Liver Disease in Different Ethnicities Globally. Journal of Clinical and Translational Hepatology 2020; 0(000): 1 doi: 10.14218/JCTH.2020.00082
|
| 71 |
Masoumeh Dorosti, Ali Jafary Heidarloo, Farnush Bakhshimoghaddam, Mohammad Alizadeh. Whole-grain consumption and its effects on hepatic steatosis and liver enzymes in patients with non-alcoholic fatty liver disease: a randomised controlled clinical trial. British Journal of Nutrition 2020; 123(3): 328 doi: 10.1017/S0007114519002769
|
| 72 |
Oluyemi Komolafe, Elena Buzzetti, Audrey Linden, Lawrence MJ Best, Angela M Madden, Danielle Roberts, Thomas JG Chase, Dominic Fritche, Suzanne C Freeman, Nicola J Cooper, Alex J Sutton, Elisabeth Jane Milne, Kathy Wright, Chavdar S Pavlov, Brian R Davidson, Emmanuel Tsochatzis, Kurinchi Selvan Gurusamy. Nutritional supplementation for nonalcohol-related fatty liver disease: a network meta-analysis. Cochrane Database of Systematic Reviews 2021; 2021(7) doi: 10.1002/14651858.CD013157.pub2
|
| 73 |
Jennifer K. Frediani, Eric A. Naioti, Miriam B. Vos, Janet Figueroa, Carmen J. Marsit, Jean A. Welsh. Arsenic exposure and risk of nonalcoholic fatty liver disease (NAFLD) among U.S. adolescents and adults: an association modified by race/ethnicity, NHANES 2005–2014. Environmental Health 2018; 17(1) doi: 10.1186/s12940-017-0350-1
|
| 74 |
Kevan Josloff, Jacob Beiriger, Adnan Khan, Richard J. Gawel, Richard S. Kirby, Aaron D. Kendrick, Abhinav K. Rao, Roy X. Wang, Michelle M. Schafer, Margaret E. Pearce, Kashyap Chauhan, Yash B. Shah, Gregary D. Marhefka, Dina Halegoua-DeMarzio. Comprehensive Review of Cardiovascular Disease Risk in Nonalcoholic Fatty Liver Disease. Journal of Cardiovascular Development and Disease 2022; 9(12): 419 doi: 10.3390/jcdd9120419
|
| 75 |
Ryan W. Walker, Gillian M. Belbin, Elena P. Sorokin, Tielman Van Vleck, Genevieve L. Wojcik, Arden Moscati, Christopher R. Gignoux, Judy Cho, Noura S. Abul-Husn, Girish Nadkarni, Eimear E. Kenny, Ruth J.F. Loos. A common variant in PNPLA3 is associated with age at diagnosis of NAFLD in patients from a multi-ethnic biobank. Journal of Hepatology 2020; 72(6): 1070 doi: 10.1016/j.jhep.2020.01.029
|
| 76 |
Toshiya Machida, Taku Obara, Makoto Miyazaki, Jun Inoue, Nariyasu Mano. Trends in drug prescriptions for type 2 diabetes, hypertension, and dyslipidemia among adults with non-alcoholic fatty liver disease. Annals of Hepatology 2022; 27(4): 100699 doi: 10.1016/j.aohep.2022.100699
|
| 77 |
Maggie A. Stanislawski, Jessica Shaw, Elizabeth Litkowski, Ethan M. Lange, Wei Perng, Dana Dabelea, Leslie A. Lange. Genetic Risk for Hepatic Fat among an Ethnically Diverse Cohort of Youth: The Exploring Perinatal Outcomes among Children Study. The Journal of Pediatrics 2020; 220: 146 doi: 10.1016/j.jpeds.2020.01.031
|
| 78 |
P. Barton Duell, Francine K. Welty, Michael Miller, Alan Chait, Gmerice Hammond, Zahid Ahmad, David E. Cohen, Jay D. Horton, Gregg S. Pressman, Peter P. Toth. Nonalcoholic Fatty Liver Disease and Cardiovascular Risk: A Scientific Statement From the American Heart Association. Arteriosclerosis, Thrombosis, and Vascular Biology 2022; 42(6) doi: 10.1161/ATV.0000000000000153
|
| 79 |
Moloud Fakhri, Hafez Fakheri, Mohammad Azadbakht, Mahmood Moosazadeh, Seyde Sedighe Yousefi. Effect of Medicinal Plants and Natural Products on Liver Enzymes in Non-alcoholic Fatty Liver Patients in Iran. International Journal of Preventive Medicine 2022; 13(1): 87 doi: 10.4103/ijpvm.IJPVM_313_20
|
| 80 |
Tong-shuo Zhang, Hua-lei Qin, Tong Wang, Hai-tao Li, Hai Li, Shi-hai Xia, Xiao-hui Xiang. Global publication trends and research hotspots of nonalcoholic fatty liver disease: a bibliometric analysis and systematic review. SpringerPlus 2015; 4(1) doi: 10.1186/s40064-015-1542-1
|
| 81 |
Paulina Vidal-Cevallos, Ana L. Ordóñez-Vázquez, Omar Procopio-Mosso, Rafael Cardoso-Arias, Misael Uribe, Norberto C. Chávez-Tapia. Cross-sectional pilot study to assess primary healthcare workers’ knowledge of nonalcoholic fatty liver disease in a marginalized community in Mexico. Scientific Reports 2021; 11(1) doi: 10.1038/s41598-021-91199-y
|
| 82 |
Yu-Tao Zhan, Hai-Ying Su, Wei An. Glycosyltransferases and non-alcoholic fatty liver disease. World Journal of Gastroenterology 2016; 22(8): 2483-2493 doi: 10.3748/wjg.v22.i8.2483
|
| 83 |
Amjad M. Ahmed, Mohamed E. Ebid, Amr M. Ajlan, Mouaz H. Al-Mallah. Low-dose attenuation correction in diagnosis of non-alcoholic fatty liver disease. Abdominal Radiology 2017; 42(10): 2454 doi: 10.1007/s00261-017-1166-8
|
| 84 |
Kurinchi Selvan Gurusamy, Emmanuel Tsochatzis, Angela M Madden. Lifestyle modifications for non-alcohol related fatty liver disease: a network meta-analysis. Cochrane Database of Systematic Reviews 2018; doi: 10.1002/14651858.CD013156
|
| 85 |
Marica Meroni, Miriam Longo, Giada Tria, Paola Dongiovanni. Genetics Is of the Essence to Face NAFLD. Biomedicines 2021; 9(10): 1359 doi: 10.3390/biomedicines9101359
|
| 86 |
Reza Ataei Kachouei, Alireza Doagoo, Maral Jalilzadeh, Seyyed Hossein Khatami, Shima Rajaei, Ali Jahanbazi Jahan-Abad, Farzaneh Salmani, Roya Pakrad, Somayeh Mahmoodi Baram, Mitra Nourbakhsh, Mohammad-Amin Abdollahifar, Hojjat Allah Abbaszadeh, Shokoofeh Noori, Mitra Rezaei, Meisam Mahdavi, Mohammad Reza Shahmohammadi, Saeed Karima. Acetyl-11-Keto-Beta-Boswellic Acid Has Therapeutic Benefits for NAFLD Rat Models That Were Given a High Fructose Diet by Ameliorating Hepatic Inflammation and Lipid Metabolism. Inflammation 2023; 46(5): 1966 doi: 10.1007/s10753-023-01853-y
|
| 87 |
Monica A. Tincopa, Luis Antonio Díaz, Daniel Q. Huang, Juan Pablo Arab, Marco Arrese, Adrian Gadano, Claudia P. Oliveira, Richele Bettencourt, Egbert Madamba, Susy Kim, Harris Siddiqi, Fernando Javier Barreyro, Sebastián Marciano, Jorge Martínez Morales, Cristiane Villela-Nogueira, Nathalie Leite, Claudia Alves Couto, Rafael Theodoro, Mísia Joyner de Sousa Dias Monteiro, Mario G. Pessoa, Mario Reis Alvares-da-Silva, Fatima Higuera de la Tijera, Constanza D. Sabate, Manuel Mendizabal, Lisa Richards, Claude B. Sirlin, Rohit Loomba. Disparities in screening and risk stratification for Hispanic adults with metabolic dysfunction–associated steatotic liver disease. Hepatology 2024; doi: 10.1097/HEP.0000000000001121
|
| 88 |
Stanislav Kotlyarov. Immune and metabolic cross-links in the pathogenesis of comorbid non-alcoholic fatty liver disease. World Journal of Gastroenterology 2023; 29(4): 597-615 doi: 10.3748/wjg.v29.i4.597
|
| 89 |
|
| 90 |
Yvonne N. Flores, Aryana T. Amoon, Baolong Su, Rafael Velazquez-Cruz, Paula Ramírez-Palacios, Jorge Salmerón, Berenice Rivera-Paredez, Janet S. Sinsheimer, Aldons J. Lusis, Adriana Huertas-Vazquez, Sammy Saab, Beth A. Glenn, Folasade P. May, Kevin J. Williams, Roshan Bastani, Steven J. Bensinger. Serum lipids are associated with nonalcoholic fatty liver disease: a pilot case-control study in Mexico. Lipids in Health and Disease 2021; 20(1) doi: 10.1186/s12944-021-01526-5
|
| 91 |
Alaa Ahmed Abd El Hamid, Azza Emam Mohamed, Manal sabry Mohamed, Ghada Essam El-Din Amin, Hagar Ahmed Ahmed Elessawy, Mohamed Farouk Allam. The effect of probiotic supplementation on non-alcoholic fatty liver disease (NAFLD) fibrosis score in patients attending a tertiary hospital clinic in Cairo, Egypt. BMC Gastroenterology 2024; 24(1) doi: 10.1186/s12876-024-03424-3
|
| 92 |
Hai Duc Nguyen, Min-Sun Kim. Cadmium, lead, and mercury mixtures interact with non-alcoholic fatty liver diseases. Environmental Pollution 2022; 309: 119780 doi: 10.1016/j.envpol.2022.119780
|
| 93 |
Mehmet Sayiner, Aaron Koenig, Linda Henry, Zobair M. Younossi. Epidemiology of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis in the United States and the Rest of the World. Clinics in Liver Disease 2016; 20(2): 205 doi: 10.1016/j.cld.2015.10.001
|
| 94 |
Stephanie M. Rutledge, Emily R. Soper, Ning Ma, Vikas Pejaver, Scott L. Friedman, Andrea D. Branch, Eimear E. Kenny, Gillian M. Belbin, Noura S. Abul-Husn. Association of HSD17B13 and PNPLA3 With Liver Enzymes and Fibrosis in Hispanic/Latino Individuals of Diverse Genetic Ancestries. Clinical Gastroenterology and Hepatology 2023; 21(10): 2578 doi: 10.1016/j.cgh.2022.12.025
|
| 95 |
Miguel Suárez, Raquel Martínez, Ana María Torres, Antonio Ramón, Pilar Blasco, Jorge Mateo. A Machine Learning-Based Method for Detecting Liver Fibrosis. Diagnostics 2023; 13(18): 2952 doi: 10.3390/diagnostics13182952
|
| 96 |
Ankit P. Laddha, Lindsey Dzielak, Cedric Lewis, Raymond Xue, José E. Manautou. Impact of non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH) on the expression and function of hepatobiliary transporters: A comprehensive mechanistic review. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 2024; 1870(3): 167037 doi: 10.1016/j.bbadis.2024.167037
|
| 97 |
Paulo S. Pinheiro, Heidy N. Medina, Karen E. Callahan, Patricia D. Jones, Clyde P. Brown, Sean F. Altekruse, Katherine A. McGlynn, Erin N. Kobetz. The association between etiology of hepatocellular carcinoma and race‐ethnicity in Florida. Liver International 2020; 40(5): 1201 doi: 10.1111/liv.14409
|
| 98 |
Meng-Yuan Wu, Jian-Gao Fan. Gut microbiome and nonalcoholic fatty liver disease. Hepatobiliary & Pancreatic Diseases International 2023; 22(5): 444 doi: 10.1016/j.hbpd.2023.06.006
|